Syncom Formulations (India) Ltd. is a prominent pharmaceutical company engaged in the manufacturing and distribution of a wide range of pharmaceutical products, primarily involving formulations. The company's product offerings encompass a vast array of therapeutic segments including antibiotics, gastrointestinal, vitamins, anti-inflammatory, and cardiovascular drugs. Syncom Formulations stands as a significant player in the pharmaceutical industry within India, leveraging extensive research and development capabilities to enhance its product portfolio and meet growing healthcare demands.
This company caters to both the domestic market and international markets, ensuring compliance with stringent industry standards. Headquartered in Mumbai, India, Syncom Formulations strives to provide affordable and quality healthcare solutions. A key characteristic of the company is its robust distribution network, which facilitates the efficient reach of its products to various healthcare providers and retailers across multiple regions. In the financial market, Syncom Formulations (India) Ltd. plays a crucial role in contributing to the healthcare sector's growth, supporting public health outcomes, and maintaining a competitive edge through innovation and strategic expansion.